Hs-CRP may be potent biomarker of uncontrolled asthma among children

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-12-13 04:30 GMT   |   Update On 2023-01-04 06:07 GMT
Advertisement

INDIA: A recent research article published in the Journal of Asthma has concluded that high-sensitivity C reactive protein (hs-CRP) is an important biomarker in asthmatic control. The study reported a higher serum hs-CRP level in children with uncontrolled asthma.

Asthma is a condition of chronic airway inflammation, and hs-CRP is a sensitive biomarker in low-grade chronic inflammation. Its role in asthma has not been studied thoroughly.

Advertisement

Previous studies have concluded that "hs-CRP could be a surrogate marker which indirectly reflects the degree of inflammation of the airway.

There needs to be more data on a hs-CRP biomarker in paediatric asthmatic patients for airway inflammation.

Adding more relevant data, a study was conducted by a team of researchers led by Dr Arwind Kumar from the Pediatric Pulmonology and Intensive Care Division of the Department of Pediatrics and Department of Cardiac Biochemistry at CN Center of All India Institute of Medical Sciences to examine,

What is the correlation between hs-CRP and asthma control levels?

The critical points of the study are:

• The study enrolled 150 children with a history of asthma (physician-diagnosed).

• The children enrolled in the study were aged 6 to 15 years.

• GINA-2016 criteria assessed the level of control of asthma.

• Assessment of the relationships between serum hs-CRP and asthma control measures (Asthma control criteria, impulse oscillometry, eosinophil counts, spirometry and Fractional exhaled nitric oxide (FeNO) were done.

• Fifty-two children constituting 35%, had well-controlled asthma.

• Seventy-six children constituting 51%, had a history of partly controlled asthma.

• Twenty-two children constituting 14%, had uncontrolled asthma.

• In well-controlled, partly-controlled, and uncontrolled asthma, median values as 0.47 mg/L, 0.30 mg/L and 2.74 mg/L for Hs – CRP. The p-value was 0.029.

• The area under the curve (ROC curve analysis) had a hs-CRP of 0.67 (for discriminating between uncontrolled and controlled asthma).

• The cutoff 1.1 mg/L of hs-CRP level in serum had a sensitivity and specificity of 68.1% and 67.97%, respectively.

• In two groups with hs-CRP of < 3 mg/L and ≥ 3 mg/L, there was a higher proportion of uncontrolled asthmatic children in the high hs-CRP group with a p-value of 0.03.

The researchers said, "We observed higher serum hs-CRP values in children with uncontrolled asthma. The findings of our study suggest that hs-CRP is a potential biomarker of asthma control."

Further reading:

Arvind Kumar, Kana Ram Jat, Jhuma Sankar, R Lakshmy, Rakesh Lodha & SK Kabra (2022) ROLE OF HIGH- SENSITIVITY C REACTIVE PROTEIN (hs-CRP) IN ASSESSMENT OF ASTHMA CONTROL IN CHILDREN, Journal of Asthma, DOI: 10.1080/02770903.2022.2155187

Tags:    
Article Source : Journal of Asthma

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News